SCHEMBL6770965

SCHEMBL6770965

O=C(O)C1(NS(=O)(=O)c2ccc3c(c2)oc2ccccc23)CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLG P00747 1/20 0.52
▸ PLAU P00749 1/20 0.52
▸ TSHR P16473 2/20 0.51
▸ MMP13 P45452 10/20 0.48
▸ MMP1 P03956 8/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ TP53 P04637 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ MMP12 P39900 3/20 0.44
▸ HTT P42858 4/20 0.43
▸ USP2 O75604 3/20 0.43
▸ LMNA P02545 3/20 0.43
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ PTGDR Q13258 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6772598 0.90 HTT (0.55) PLGPLAUTSHRMMP13ALDH1A1
SCHEMBL6770863 0.89 MMP1 (0.60) MMP13MMP1MMP12
Hydroxyamine SCHEMBL7578513 0.88 HTT (0.53) PLGPLAUTSHRMMP13ALDH1A1
SCHEMBL6417494 0.86 MMP12 (0.56) TSHRMMP13ALDH1A1SMN1; SMN2TP53
SCHEMBL7065810 0.83 SMN1; SMN2 (0.55) PLGPLAUTSHRMMP13ALDH1A1
SCHEMBL6874205 0.80 TSHR (0.47) TSHRMMP13MMP1ALDH1A1SMN1; SMN2
SCHEMBL6771108 0.79 MMP1 (0.51) MMP13MMP1ALDH1A1SMN1; SMN2HTT
SCHEMBL7454421 0.77 PLAU (0.46) PLGPLAUMMP13ALDH1A1SMN1; SMN2
SCHEMBL23673553 0.77 USP2 (0.51) PLGPLAUMMP13SMN1; SMN2MMP12
SCHEMBL6772621 0.76 USP2 (0.49) PLGPLAUMMP13ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1210326-B1 HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALLOPROTEINASE INHIBITORS WARNER LAMBERT CO (US) 2004-02-25 — — EP disclosed
US-6677355-B1 DIBENZOFURAN-3-(SULFONYLAMINO OR SULFINAMINO) DERIVATIVES; MULTIPLE SCLEROSIS, ATHEROSCLEROSIS, HEART FAILURE, PERIODONTAL DISEASE, OSTEOARTHRITIS, AUTOIMMUNE DISEASE; ANTICARCINOGENIC AGENTS WARNER-LAMBERT COMPANY 2004-01-13 — — US disclosed
EP-1210326-A2 HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-06-05 — — EP disclosed
WO-2001012592-A2 HYDROXAMIC ACID COMPOUNDS USEFUL AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-02-22 — — WO disclosed
Send feedback